Fumimasa Watanabe

SARS-CoV-2 spike protein antibody titers 6 months after SARS-CoV-2 mRNA vaccination among patients undergoing hemodialysis in Japan

Y. Toya, N. Hirawa, H. Kato, 2022, Clinical and Experimental Nephrology.

Improved Immune Response to the Third COVID-19 mRNA Vaccine Dose in Hemodialysis Patients

Y. Toya, N. Hirawa, H. Kato, 2022, Kidney International Reports.

Blunted humoral immune response to the fourth dose of BNT162b2 COVID-19 vaccine in patients undergoing hemodialysis

Y. Toya, N. Hirawa, H. Kato, 2023, Clinical and Experimental Nephrology.